New Members Join MBCA in 2025: Unity, Vision, and Dedication
The Metastatic Breast Cancer Alliance (MBCA) is excited to welcome new members to its coalition in 2025. As a national leader in collaborative action, the Alliance continues its mission to transform and improve the lives of people living with metastatic breast cancer. This work includes a strategic focus on advancing research, making clinical trials more patient-centric, removing barriers to standard of care, and integrating quality of life services and care into all treatment planning.
Meet Our New Members as of 2025
NEW INDIVIDUAL MEMBERS
Amy Russell-Parliman
Amy holds a Master’s in Health Administration and serves as a Director of Diagnostic Imaging for a health system in upstate New York, but the accent is all Georgia. After an early stage breast cancer diagnosis in 2014, Amy was diagnosed with metastatic lobular invasive carcinoma in 2019. Amy’s advocacy efforts since her MBC diagnosis includes serving as the Social Media guru for Project Life, she is trained as a mentor for MBC patients, completing the Hear My Voice Program through LBBC in 2022, serving as a patient advocate for DOD grants, teaching others about diagnostic testing through Spinning Science and elsewhere, serving on the MBC Leadership Committee for SurvivingBreastCancer.org, serving as a individual member of the Metastatic Breast Cancer Alliance and so much more. Amy is married to her sweetheart, Chris, and they have three fur babies who run their household. Learn more.
NEW NONPROFIT MEMBERS
For the Breast of Us
For the Breast of Us is a pioneering organization dedicated to uplifting and supporting women of color impacted by breast cancer. Our mission is to bridge the gap in care and information, ensuring all women, regardless of background, have access to the resources, support, and advocacy needed to navigate their breast cancer journey.
Learn more.
NEW INDUSTRY MEMBERS
TerSera Therapeutics
TerSera’s one-of-a-kind approach combines clinical expertise with a patient-first mentality to deliver therapeutics that transform patients’ lives. They follow the science to uncover and expand new possibilities for patients.
Learn more.